Hongxin Deng
- Immunology top 5%
- Immunotherapy and Immune Responses 20
- Oncology top 5%
- Cancer-related Molecular Pathways 10
- CAR-T cell therapy research 10
- Cancer Research top 5%
- Molecular Medicine top 5%
- Biomaterials top 5%
-
- RNA Interference and Gene Delivery 18
- Angiogenesis and VEGF in Cancer 15
- RNA modifications and cancer 11
-
- Cancer Research and Treatments 14
-
- Virus-based gene therapy research 10
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (1 paper)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hongxin Deng
125 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 122
- Immunology 555
- Oncology 623
- Cancer Research 310
- Molecular Medicine 83
- Biomaterials 203
Countries citing papers authored by Hongxin Deng
This map shows the geographic impact of Hongxin Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxin Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxin Deng more than expected).
Fields of papers citing papers by Hongxin Deng
This network shows the impact of papers produced by Hongxin Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxin Deng. The network helps show where Hongxin Deng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongxin Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 19 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 33 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 37 | |
| 10 | 2019 | 62 | |
| 11 | 2016 | 43 | |
| 12 | 2012 | 1 | |
| 13 | 2012 | 11 | |
| 14 | 2011 | 10 | |
| 15 | 2009 | 49 | |
| 16 | 2009 | 16 | |
| 17 | 2009 | 12 | |
| 18 | 2008 | 11 | |
| 19 | 2007 | 2 | |
| 20 | 2003 | 55 |
About Hongxin Deng
Hongxin Deng is a scholar working on Biotechnology, Immunology and Cancer Research, having authored 128 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (20 papers), RNA Interference and Gene Delivery (18 papers), Angiogenesis and VEGF in Cancer (15 papers), Cancer Research and Treatments (14 papers), RNA modifications and cancer (11 papers), Cancer-related Molecular Pathways (10 papers), Virus-based gene therapy research (10 papers) and CAR-T cell therapy research (10 papers). The work is most often cited by research in Immunology (555 citations), Oncology (623 citations) and Cancer Research (310 citations). Hongxin Deng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yuquan Wei, Lei Dai, Dechao Yu, Xia Zhao, Xiaolan Su, Lin Cheng, Shuang Zhang, Zhiyong Qian, Lijuan Chen and Jiong Li. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.